Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.55 |
| ▸ | CCR5 | P51681 | 3/20 | 0.55 |
| ▸ | CCR8 | P51685 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.53 |
| ▸ | LMNA | P02545 | 6/20 | 0.53 |
| ▸ | TP53 | P04637 | 6/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29505007 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL21849866 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL30943430 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL30943427 | 1.00 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL3320940 | 0.97 | CCR1 (0.51) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL19320191 | 0.94 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL4401831 | 0.94 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL3319965 | 0.94 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL3315795 | 0.94 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ESMN1; SMN2 | |
| SCHEMBL7546741 | 0.92 | CCR1 (0.47) | CCR1CCR5CCR8KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104926819-B | Synthetic method and its anti-human liver cancer the HepG2 activity of 2,8 diaryl (amino) Chao Geer alkali derivants | 江苏师范大学 | 2017-11-03 | — | — | CN | claimed |
| EP-0885233-B1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION (GB) | 2002-06-19 | — | — | EP | claimed |
| US-12404280-B2 | Heterocyclic compound, and organic light-emitting element using same | LT MATERIALS CO., LTD. (KR) | 2025-09-02 | — | — | US | disclosed |
| WO-2025018655-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 진웅산업 | 2025-01-23 | — | — | WO | disclosed |
| US-20250000979-A1 | TRIPLET-TRIPLET ENERGY TRANSFER WITH LIGHT EXCITATION AT LONG WAVELENGTHS AND METHODS THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2025-01-02 | — | — | US | disclosed |
| CN-118206774-A | Non-fully conjugated metal-supermolecular polymer and preparation method and application thereof | 河南大学 | 2024-06-18 | — | — | CN | disclosed |
| US-20240099130-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2024-03-21 | — | — | US | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| US-11891361-B2 | Heterocyclic compound and organic light emitting device comprising same | LT MATERIALS CO., LTD. (KR) | 2024-02-06 | — | — | US | disclosed |
| US-11856847-B2 | Organic light emitting display device | LG DISPLAY CO., LTD. (KR) | 2023-12-26 | — | — | US | disclosed |
| CN-115414965-B | Preparation method and application of terpyridyl supermolecular photocatalyst | 河北科技大学 | 2023-11-28 | — | — | CN | disclosed |
| WO-2004111110-A1 | PROCESS FOR THE PRODUCTION OF AN ISOTROPIC POLYMERIC NETWORK | DSM IP ASSETS B.V. (NL) | 2004-12-23 | — | — | WO | disclosed |
| EP-1486527-A1 | Process for the production of an isotropic polymeric network | DSM IP Assets B.V. (NL) | 2004-12-15 | — | — | EP | disclosed |
| WO-2004041913-A1 | ELECTROLUMINESCENT METALLO-SUPRAMOLECULES WITH TERPYRIDINE-BASED GROUPS | THE UNIVERSITY OF HONG KONG (CN) | 2004-05-21 | — | — | WO | disclosed |
| US-20040086744-A1 | Electroluminescent metallo-supramolecules with terpyridine-based groups | VERSITECH LIMITED (CN) | 2004-05-06 | — | — | US | disclosed |
| EP-0885233-B1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION (GB) | 2002-06-19 | — | — | EP | disclosed |
| US-20020013306-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2002-01-31 | — | — | US | disclosed |
| EP-1164138-A1 | Terpyridine-platinum (II) complexes | ISIS INNOVATION LIMITED (GB) | 2001-12-19 | — | — | EP | disclosed |
| EP-0885233-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997027202-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891361-B2 | Heterocyclic compound and organic light emitting device comprising same | CRY1, CYP1A1, CYP1B1 | CCR1 1738/4885CCR5 2950/4885CCR8 3481/4885 |
| US-20240099130-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | OCIAD1, OCIAD2, AOX1 | CCR1 3128/4885CCR5 1296/4885CCR8 1875/4885 |
| US-20020013306-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | TOP2A, TOP1, TOP2B | CCR1 1921/4885CCR5 884/4885CCR8 1209/4885 |
| US-20250000979-A1 | TRIPLET-TRIPLET ENERGY TRANSFER WITH LIGHT EXCITATION AT LONG WAVELENGTHS AND METHODS THEREOF | TTPA, TST, TK1 | CCR1 4678/4885CCR5 4844/4885CCR8 4454/4885 |
| US-12404280-B2 | Heterocyclic compound, and organic light-emitting element using same | CRY1, CYP1A1, CYP1B1 | CCR1 2368/4885CCR5 3675/4885CCR8 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.